Cargando…
中国肺癌低剂量CT筛查指南(2023年版)
Lung cancer is the leading cause of cancer-related death in China. The effectiveness of low-dose computed tomography (LDCT) screening has been further validated in recent years, and significant progress has been made in research on identifying high-risk individuals, personalizing screening interval,...
Autores principales: | Chinese Expert Group on Early Diagnosis and Treatment of Lung Cancer, China Lung Oncology Group |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987116/ https://www.ncbi.nlm.nih.gov/pubmed/36792074 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.10 |
Ejemplares similares
-
中国肺癌低剂量螺旋CT筛查指南(2018年版)
Publicado: (2018) -
低剂量螺旋CT肺癌筛查研究进展
Publicado: (2013) -
低剂量螺旋CT肺癌筛查研究进展
Publicado: (2020) -
低剂量螺旋CT在肺癌筛查中的应用
Publicado: (2022) -
Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer
por: Non-small Cell Lung Cancer Expert Committee of Chinese Society of Clinical Oncology,, et al.
Publicado: (2023)